Aldeyra The

Company Profile

Aldeyra The had its IPO on 2014-05-02 under the ticker symbol ALDX.

The company operates in the Healthcare sector and Biotechnology industry. Aldeyra The has a staff strength of 15 employees.

Stock update

Shares of Aldeyra The opened at $9.45 at the start of the last trading session i.e. 2023-03-30.

The stocks traded within a range of $9.18 - $9.55, and closed at $9.5.

This is a +0.53% increase from the previous day's closing price.

A total volume of 771,490 shares were traded at the close of the day’s session.

In the last one week, shares of Aldeyra The have increased by +17.87%.

Aldeyra The's Key Ratios

Aldeyra The has a market cap of $425.73 million, indicating a price to book ratio of 2.2385 and a price to sales ratio of 0.

In the last 12-months Aldeyra The’s revenue was $0 with a gross profit of $0 and an EBITDA of $-64134104. The EBITDA ratio measures Aldeyra The's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aldeyra The’s operating margin was 0% while its return on assets stood at -18.42% with a return of equity of -33.98%.

In Q3, Aldeyra The’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Aldeyra The’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-1.17 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aldeyra The’s profitability.

Aldeyra The stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -3.0754. Its price to sales ratio in the trailing 12-months stood at 0.

Aldeyra The stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$189.69 million

Total Liabilities

$24.20 million

Operating Cash Flow

$19.02 million

Capital Expenditure

$0

Dividend Payout Ratio

0%

Aldeyra The ended 2023 with $189.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $189.69 million while shareholder equity stood at $162.19 million.

Aldeyra The ended 2023 with $0 in deferred long-term liabilities, $24.20 million in other current liabilities, 58560.00 in common stock, $-343814476.00 in retained earnings and $0 in goodwill. Its cash balance stood at $128.65 million and cash and short-term investments were $185.33 million. The company’s total short-term debt was $12,633,657 while long-term debt stood at $3.30 million.

Aldeyra The’s total current assets stands at $189.48 million while long-term investments were $0 and short-term investments were $56.68 million. Its net receivables were $21.50 million compared to accounts payable of $1.31 million and inventory worth $0.

In 2023, Aldeyra The's operating cash flow was $19.02 million while its capital expenditure stood at $0.

Comparatively, Aldeyra The paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$9.5

52-Week High

$7.99

52-Week Low

$2.355

Analyst Target Price

$19.88

Aldeyra The stock is currently trading at $9.5 per share. It touched a 52-week high of $7.99 and a 52-week low of $7.99. Analysts tracking the stock have a 12-month average target price of $19.88.

Its 50-day moving average was $7.12 and 200-day moving average was $6.08 The short ratio stood at 6.44 indicating a short percent outstanding of 0%.

Around 234.9% of the company’s stock are held by insiders while 6010% are held by institutions.